Pfizer Inc that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyxs lead compound, Fosmanogepix (APX001), is a novel investigational asset under development for the treatment of invasive fungal infections.
- Read more about Pfizer Acquires Amplyx Pharmaceuticals
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/pfizer-acquires-amplyx-pharmaceuticals
No comments:
Post a Comment